Oracle Partners with Wipro to Strengthen End-to-End Pharmacovigilance Services
Get Alerts ORCL Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.7%
EPS Growth %: -16.4%
Join SI Premium – FREE
Collaboration to help life sciences organizations accelerate pharmacovigilance deployment with built-in compliance support
"Life sciences organizations are under increasing pressure to modernize safety operations while maintaining compliance and speed," said
Oracle Argus BPS provides the foundation for scalable, cloud-based pharmacovigilance services
Oracle Life Sciences Argus is a leading pharmacovigilance solution that helps organizations manage drug safety data, automate workflows, support regulatory reporting, and provide visibility across safety operations. Oracle Life Sciences Argus BPS extends that foundation into a cloud-based, managed services model, providing flexible infrastructure, and built-in compliance capabilities. The cloud-based managed services model enables organizations like Wipro to deliver scalable pharmacovigilance (PV) services without the burden of maintaining on-premises safety systems.
Wipro's PV services span case processing, reporting, regulatory submissions, Qualified Person for Pharmacovigilance (QPPV) support, and post-marketing surveillance.
To help customers accelerate results, Wipro is adopting a go-to-market model in which preconfigured Oracle Life Sciences Argus BPS environments are maintained and deployment-ready prior to customer onboarding. This approach can help streamline implementation timelines and accelerate the delivery of PV operations once deployment begins.
"Our collaboration with Wipro reflects the growing demand for comprehensive, cloud-based pharmacovigilance solutions that help life sciences organizations modernize safety operations and accelerate drug development," said
Learn about how customers, partners, and CROs are using Oracle's unified life sciences platform to streamline drug safety operations, accelerate PV service delivery, and support regulatory compliance across the full drug lifecycle from clinical development through post-marketing surveillance at www.oracle.com/lifesciences.
About Oracle Life Sciences
Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements—empowering the life sciences industry to improve patient outcomes. Learn more at www.oracle.com/lifesciences.
About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.
Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.
View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-partners-with-wipro-to-strengthen-end-to-end-pharmacovigilance-services-302883750.html
SOURCE Oracle
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle and Wipro partner on cloud pharmacovigilance services
- Gao Zhikai:China-U.S. relations must be stable and strategic
- Oracle and Buck Institute to collaborate on aging research data
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
ArgusSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share